(Q43030608)

12 November 2017

title

Antiviral treatment withdrawal in viremic HCV-positive liver transplant patients: impact on viral loads, allograft function and morphology (English)

1 reference

12 November 2017

1 reference

Arno Kornberg

1

1 reference

12 November 2017

Bernadett Küpper

2

1 reference

12 November 2017

Andrea Tannapfel

3

1 reference

12 November 2017

Katharina Thrum

4

1 reference

12 November 2017

Erik Bärthel

5

1 reference

12 November 2017

Utz Settmacher

6

1 reference

12 November 2017

language of work or name

1 reference

1 September 2006

1 reference

12 November 2017

1 reference

12 November 2017

volume

26

1 reference

12 November 2017

issue

7

1 reference

12 November 2017

page(s)

811-816

1 reference

The natural history and outcome of liver transplantation in hepatitis C virus-infected recipients

12 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2006.01301.X

Report of the first International Liver Transplantation Society expert panel consensus conference on liver transplantation and hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2006.01301.X

Long-term combination of interferon alfa-2b and ribavirin for hepatitis C recurrence in liver transplant patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2006.01301.X

Treatment of posttransplantation recurrence of hepatitis C with interferon and ribavirin: lessons on tolerability and efficacy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2006.01301.X

Interferon-alpha and ribavirin for the treatment of recurrent hepatitis C after liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2006.01301.X

Interferon-alpha 2b plus ribavirin in patients with chronic hepatitis C after liver transplantation: a randomized study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2006.01301.X

Long term histological improvement and clearance of intrahepatic hepatitis C virus RNA following sustained response to interferon-ribavirin combination therapy in liver transplanted patients with hepatitis C virus recurrence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2006.01301.X

Sustained viral response to interferon and ribavirin in liver transplant recipients with recurrent hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2006.01301.X

Histological grading and staging of chronic hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2006.01301.X

Effects of interferon treatment on liver histology and allograft rejection in patients with recurrent hepatitis C following liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2006.01301.X

Benefit of sustained virological response to combination therapy on graft survival of liver transplanted patients with recurrent chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2006.01301.X

Treatment of recurrent hepatitis C in liver transplants: efficacy of a six versus a twelve month course of interferon alfa 2b with ribavirin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2006.01301.X

Clinical and histologic patterns of early graft failure due to recurrnet hepatitis C in four patients after liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2006.01301.X

Rapidly progressive fibrosing cholestatic hepatitis--hepatitis C virus in HIV coinfection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2006.01301.X

Liver transplantation and hepatitis C virus: systematic review of antiviral therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2006.01301.X

Management of hepatitis C virus infection in the setting of liver transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2006.01301.X

10.1111/J.1478-3231.2006.01301.X

21 January 2018

Identifiers

DOI

1 reference

12 November 2017

1 reference